Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction

Ryuji Kato(Nagoya University), Jack Uetrecht(University of Toronto)
The Journal of Toxicological Sciences
January 1, 2020
10.2131/jts.45.673
Cited by 26

Related Papers

Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges
|International Journal of Molecular Sciences|2021|97
The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions
|Drug Metabolism and Disposition|2019|27
Regorafenib and reactive metabolite of sunitinib activate inflammasomes: Implications for multi tyrosine kinase inhibitor-Iiduced immune related adverse events
|˜Die œPharmazie|2022|4